Results

eNauka >  Results >  Clinical Outcomes and Immune-Related Adverse Events in Metastatic Non-Squamous NSCLC Treated with First-Line Pembrolizumab-Chemotherapy: A Real-World Study from Serbia
Title: Clinical Outcomes and Immune-Related Adverse Events in Metastatic Non-Squamous NSCLC Treated with First-Line Pembrolizumab-Chemotherapy: A Real-World Study from Serbia
Authors: Bojic, Zlatan; Markovic, Filip; Kontic, Milica Dj
Issue Date: 2026
Publication: CURRENT ONCOLOGY
ISSN: 1198-0052 Current Oncology Search Idenfier
Type: Article
Collation: vol. 33 br. 5 str. 267-267
DOI: 10.3390/curroncol33050267
WoS-ID: 001776096500001
Scopus-ID: 2-s2.0-105040258443
URI: https://enauka.gov.rs/handle/123456789/1046537
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
22M22

Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.